Novozymes | NZYMB - Cash And Equivalent


Novozymes reported 149.72M in Cash and Equivalent for its fiscal quarter ending in December of 2023.





Cash And Equivalent Change Date
Arq USD 6.57M 453K Dec/2025
Avient USD 445.6M 28.9M Sep/2025
Chemours USD 670M 57M Dec/2025
Coronado Global Resources USD 229.7M 109.92M Mar/2025
Corteva USD 4.52B 2.01B Dec/2025
Metallus USD 156.7M 34.8M Dec/2025
Newmont Corporation USD 5.64B 546M Sep/2025
Novozymes 149.72M 7.92M Dec/2023
SSR Mining USD 409.33M 2.77M Sep/2025